Renal complications in multiple myeloma: Pathophysiology and some aspects of clinical management

Bayrd, 1947, Multiple myeloma, review of 83 proved cases, JAMA, 133, 147, 10.1001/jama.1947.02880030001001 Brownell, 1955, Multiple myeloma, review of 61 proved cases, Archs intern Med, 95, 699, 10.1001/archinte.1955.00250110069008 Carson, 1955, Plasma cell myeloma. A clinical, pathologic and roentgenologic review of 90 cases, Am J Clin Path, 25, 849, 10.1093/ajcp/25.8.849 Glenchur, 1959, A review of 51 cases of multiple myeloma, Archs intern Med, 103, 173, 10.1001/archinte.1959.00270020001001 Kenny, 1957, Multiple myeloma, diagnosis and management in a series of 57 cases, Ann intern Med, 46, 1079, 10.7326/0003-4819-46-6-1079 Bryan, 1968, Acute renal failure in multiple myeloma, Amer J Med, 44, 128, 10.1016/0002-9343(68)90244-1 Leucutia, 1961, Multiple myeloma and intravenous pyelography, Amer J Roentgen, 85, 187 Sanchez, 1960, Renal patterns in myeloma, Ann intern Med, 52, 44, 10.7326/0003-4819-52-1-44 Carone, 1967, Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients, Amer J Med, 42, 937, 10.1016/0002-9343(67)90074-5 Armstrong, 1950, Study of renal function in patients with multiple myeloma, Amer J Med Sci, 219, 488, 10.1097/00000441-195005000-00003 Goldman, 1952, Renal function in multiple myeloma, J Lab Clin Med, 40, 519 Myhre, 1957, Kidney function studies in myelomatosis, Scand J Clin Lab Invest, 9, 80, 10.3109/00365515709088118 Osserman, 1969, Plasma cell myeloma. II. Clinical aspects, New Eng J Med, 261, 1006, 10.1056/NEJM195911122612006 Bell, 1933, Renal lesions associated with multiple myeloma, Amer J Path, 9, 393 MacMahon, 1956, Incidence of multiple myeloma, J Chron Dis, 4, 508, 10.1016/0021-9681(56)90070-4 Blackman, 1944, On pathogenesis of renal failure associated with multiple myeloma: electrophoretic and chemical analysis of protein in urine and blood serum, J Clin Invest, 23, 163, 10.1172/JCI101479 Dammacco, 1968, Bence Jones proteinuria in benign monoclonal gammapathies. Incidence and characteristics, Acta Med Scand, 184, 403, 10.1111/j.0954-6820.1968.tb02479.x Harvey, 1963, Renal involvement in myeloma, amyloidosis, systemic lupus erythematosus and other diseases of connective tissue, 577 Osserman, 1955, Abnormal serum and urine proteins in 35 cases of multiple myeloma as studied by filter paper electrophoresis, Amer J Med, 18, 462, 10.1016/0002-9343(55)90227-8 Combined Staff and Clinic Conference, 1957, Multiple myeloma: Current clinical and chemical concepts, Amer J Med, 23, 283, 10.1016/0002-9343(57)90200-0 Korngold, 1956, Multiple myeloma proteins-III. Antigenic relationship of Bence Jones proteins to normal gammaglobulin and multiple myeloma serum proteins, Cancer, 9, 262, 10.1002/1097-0142(195603/04)9:2<262::AID-CNCR2820090210>3.0.CO;2-B Putnam, 1957, Aberration of protein metabolism in multiple myeloma: Interrelationships of abnormal serum globulins and Bence Jones proteins, Physiol Rev, 37, 512, 10.1152/physrev.1957.37.4.512 Fahey, 1968, Plasma cell myeloma with D-myeloma protein (1g-D myeloma), Amer J Med, 45, 373, 10.1016/0002-9343(68)90071-5 Greenwald, 1953, Needle biopsy of the kidney: A report of five cases of multiple myeloma, Amer J Med, 15, 198, 10.1016/0002-9343(53)90071-0 Milne, 1964, Renal involvement in general disease, 468 Edelman, 1962, Nature of Bence-Jones protein: Chemical similarities to polypeptide chains of myeloma globulins and normal gamma-globulins, J Exp Med, 116, 207, 10.1084/jem.116.2.207 Osserman, 1963, Plasma cell myeloma: Gammaglobulin synthesis and structure, Medicine, 42, 357, 10.1097/00005792-196311000-00001 Rees, 1966, Factors in the renal failure of multiple myeloma, Arch Intern Med, 116, 400, 10.1001/archinte.1965.03870030080013 Putnam, 1959, Plasma-cell myeloma and macroglobulinemia-I. Physicochemical, immunochemical and isotopic turnover studies of the abnormal serum and urinary proteins, New Eng J Med, 261, 902, 10.1056/NEJM195910292611806 Engle, 1957, Multiple myeloma and the adult Fanconi syndrome, Amer J Med, 22, 5, 10.1016/0002-9343(57)90333-9 Calkins, 1960, Diagnosis of amyloidosis, Bull Rheum Dis, 10, 215 Kimball, 1961, Amyloidosis in association with neoplastic disease: report of unusual case and clinicopathological experience at Memorial Center for Cancer and Allied Diseases during 11 years (1948–1958), Ann Intern Med, 55, 958, 10.7326/0003-4819-55-6-958 Cohen, 1967, Amyloidosis, New Eng J Med, 277, 628, 10.1056/NEJM196709212771205 Lindeman, 1961, Renal amyloidosis, Ann Intern Med, 54, 883, 10.7326/0003-4819-54-5-883 Churg, 1965, Idiopathic nephrotic syndrome in adults. A study and classification based on renal biopsies, New Eng J Med, 272, 165, 10.1056/NEJM196501282720401 Larcan, 1964, Syndrome nephretique et maladie de Kahler. A propos de cinq observations, Med Mond, 40, 69 MacAlister, 1961, Renal aspects of myelomatosis, Brit J Urol, 33, 141, 10.1111/j.1464-410X.1961.tb11597.x Rosen, 1967, Multiple myeloma and the nephrotic syndrome, Amer J Clin Path, 47, 567, 10.1093/ajcp/47.5.567 Squire, 1957, The nephrotic syndrome, Brit Med Bull, 13, 43, 10.1093/oxfordjournals.bmb.a069570 Heptinstall, 1966, Amyloidosis, multiple myeloma, and Waldenstrom's macroglogulinemia, 571 Linton, 1963, Immune responses in myeloma, Brit Med J, 2, 86, 10.1136/bmj.2.5349.86 Coleman, 1962, Renal lesions in in-bred mice with plasma cell tumors, Arch Path, 74, 6 Costanza, 1963, Multiple myeloma with the Fanconi syndrome, Amer J Med, 34, 125, 10.1016/0002-9343(63)90046-9 Dragsted, 1956, The association of the Fanconi syndrome with malignant disease, Danish Med Bull, 3, 177 Short, 1959, Myelomatosis associated with glycosuria and aminoaciduria, Scottish Med J, 4, 89, 10.1177/003693305900400206 Sirota, 1954, Renal function studies in adult with Fanconi syndrome, Amer J Med, 16, 138, 10.1016/0002-9343(54)90329-0 Morris, 1967, Impaired renal acidification in patients with hypergammaglobulinemia, Medicine, 46, 57, 10.1097/00005792-196701000-00003 Wochner, 1967, The role of the kidney in the catabolism of Bence-Jones proteins and immunoglobulin fragments, J Exp Med, 126, 207, 10.1084/jem.126.2.207 Mogielnicki, 1969, L-Chain catabolism in mice with experimental Fanconi syndrome produced by the renal tubular toxin, maleic acid, 28, 826 Wrong, 1959, The excretion of acid in renal disease, Quart J Med, 28, 259 Parrish, 1964, The effect of increased plasma viscosity on renal function, Clin Res, 12, 71 Somer, 1966, The viscosity of blood, plasma and serum in dys- and para-proteinemias, Acta Med Scand, 180, 1 Williams, 1968, Hyperviscosity syndrome, Circulation, 38, 450, 10.1161/01.CIR.38.3.450 Finkel, 1966, Current concepts in the therapy of multiple myeloma, Med Clin N Amer, 50, 1569, 10.1016/S0025-7125(16)33105-4 Roussak, 1954, Water losing nephritis: A syndrome simulating diabetes insipidus, Quart J Med, 23, 147 Barry, 1963, Acute uric acid nephropathy. Treatment with mannitol diuresis and peritoneal dialysis, Arch Int Med, 111, 452, 10.1001/archinte.1963.03620280052008 Rieselbach, 1964, Uric acid excretion and renal function in the acute hyperuricemia of leukemia. Pathogenesis and therapy of uric acid nephropathy, Amer J Med, 37, 872, 10.1016/0002-9343(64)90130-5 Hull, 1967, Mechanism of diuretic-induced hyperuricemia, Abstracts of the American Soc Nephrology, 31 Morgan, 1966, Intravenous urography in multiple myeloma, New Eng J Med, 275, 77, 10.1056/NEJM196607142750205 Rosenbaum, 1966, Binding of radiographic contrast media to serum proteins demonstrated by immunoelectrophoresis and radioautography, Radiology, 86, 515, 10.1148/86.3.515 Vix, 1966, Intravenous pyelography in multiple myeloma. A review of 52 studies in 40 patients, Radiology, 87, 896, 10.1148/87.5.896 Suki, 1970, Acute treatment of hypercalcemia with furosemide, New Eng J Med, 283, 836, 10.1056/NEJM197010152831603 DeConti, 1966, Use of Allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease, New Eng J Med, 274, 481, 10.1056/NEJM196603032740902 Krakoff, 1966, Use of Allopurinol in preventing hyperuricemia in leukemia and lymphoma, Cancer, 19, 1489, 10.1002/1097-0142(196611)19:11<1489::AID-CNCR2820191105>3.0.CO;2-F Krakoff, 1965, Prevention of hyperuricemia in leukemia and lymphoma. Use of Allopurinol, a xanthine oxidase inhibitor, JAMA, 193, 1, 10.1001/jama.1965.03090010007001